Converge

Developer of GenAI computational tools for drug discovery and manufacturing

placeWilmington, Delaware, United States calendar_todayFounded 2024 language converge-bio.com

Social engagement

Social engagement: 6K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include TLV Partners, Bessemer Venture Partners.

Investor typeCountShare
Venture capital375%
Private equity125%

Recent activity

24 Jun 2026
Event
webinar on drug discovery and biological research
16 Jun 2026
Event
Inside ConvergeABTM
11 Jun 2026
Event
BIO International Convention 2026
Coming soon